US › Healthcare

Impact BioMedical, Inc. (IBO)

US · Healthcare · Biotechnology

$2.68-15.15%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$3,000

Revenue YoY

-57.1%

Net profit

$-699,000

EPS

$-0.01

Net margin

-23,300.0%

Key statistics

Market cap

$29.1M

P/E

0.3

Forward P/E

0.0

P/B

5.26

Book value

$1.26

EPS (TTM)

$11.71

52-week high

$10.47

52-week low

$3.25

50-day MA

$5.68

200-day MA

$6.45

Beta

2.73

Shareholding

Insiders

89.02%

Institutions

3.56%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Impact BioMedical, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.